Clinical trial · Observational
Intra-procedural 360-degree Display for Performing Percutaneous Liver Tumor Ablation
Intra-procedural 360-degree Display for Performing Percutaneous Liver Tumor Ablation as an Adjunct to Standard Flat Panel Display
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Medical images used to guide treatment of tumor(s) are presently displayed on flat-panel monitors (like screens used with computers). This protocol will evaluate, using a new headset to view the images in true 3D ("360 degrees"), while using standard flat panel monitors as usual (in accordance with standard of care). The headset is combined with a mini-global positioning system (GPS)-like system to help navigate to treat tumor(s). This evaluation is to show that the headset has potential to provide guidance and navigation information that can improve the treatment of tumor(s) with heat.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Percutaneous Tumor Ablation | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| HoloLens | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- 360-degree Display of solid tumors
- description
- Evaluate the feed back of using the HoloLens headset to have a 360 degree visualization of patient tumors during percutaneous liver tumor ablation
- interventionNames
- Device: HoloLens
Primary outcomes (1)
- measure
- Standard System Usability Score on a Likert Scale
- timeFrame
- 1 day
- description
- The surgeons and staff completing the intervention will rate the usability of the system. An average score greater than 3 will indicate acceptability of the 360 degree display.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Not pregnant * Willing and able to give informed consent prior to enrollment. This includes media release form. * Has met all criteria to undergo percutaneous tumor ablation. Exclusion Criteria: * Not willing or able to give informed consent * Patients with pacemakers or automated implantable cardioverter defibrillator (AICDs).
References
Publications (0)
Data not yet available